Literature DB >> 7970234

Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls.

D St Clair1, J Norrman, R Perry, C Yates, G Wilcock, A Brookes.   

Abstract

Genotypes of apolipoprotein E (ApoE) were determined by polymerase-chain reaction (PCR) amplification and restriction-sizing of brain DNA from 39 cases of Lewy body dementia (LBD), 68 senile Alzheimer's disease (AD) patients and 47 neuropathologically validated non-demented controls. There was a 3-fold increase in the epsilon 4 allele frequency in both LBD and AD groups compared with controls. These results indicate that LBD and AD share the epsilon 4 allele of ApoE as a major risk factor for the development of disease and suggest a similarity in disease aetiology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970234     DOI: 10.1016/0304-3940(94)90867-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

2.  Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia.

Authors:  Shinsuke Fujioka; Christina Sundal; Audrey J Strongosky; Monica Case Castanedes; Rosa Rademakers; Owen A Ross; Carles Vilariño-Güell; Matthew J Farrer; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2012-11-04       Impact factor: 17.088

3.  APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia.

Authors:  Keith A Josephs; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Val J Lowe; Clifford R Jack; Jennifer L Whitwell
Journal:  Alzheimers Dement       Date:  2014-06-28       Impact factor: 21.566

4.  Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.

Authors:  A S Whitehead; S Bertrandy; F Finnan; A Butler; G D Smith; Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

5.  Apolipoprotein E epsilon 4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers.

Authors:  D St Clair; M Rennie; E Slorach; J Norrman; C Yates; A Carothers
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

6.  Diet and age interactions with regards to cholesterol regulation and brain pathogenesis.

Authors:  Romina M Uranga; Jeffrey N Keller
Journal:  Curr Gerontol Geriatr Res       Date:  2010-04-11

7.  Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia.

Authors:  M G Martinoli; J Q Trojanowski; M L Schmidt; S E Arnold; T M Fujiwara; V M Lee; H Hurtig; J P Julien; C Clark
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  The APOE E4 Allele Is Associated with Faster Rates of Neuroretinal Thinning in a Prospective Cohort Study of Suspect and Early Glaucoma.

Authors:  Sean Mullany; Henry Marshall; Santiago Diaz-Torres; Ella C Berry; Joshua M Schmidt; Daniel Thomson; Ayub Qassim; Minh-Son To; David Dimasi; Abraham Kuot; Lachlan S W Knight; Georgina Hollitt; Antonia Kolovos; Angela Schulz; Stewart Lake; Richard A Mills; Ashish Agar; Anna Galanopoulos; John Landers; Paul Mitchell; Paul R Healey; Stuart L Graham; Alex W Hewitt; Emmanuelle Souzeau; Mark M Hassall; Sonja Klebe; Stuart MacGregor; Puya Gharahkhani; Robert J Casson; Owen M Siggs; Jamie E Craig
Journal:  Ophthalmol Sci       Date:  2022-04-19

9.  Assessment of APOE in atypical parkinsonism syndromes.

Authors:  Marya S Sabir; Cornelis Blauwendraat; Sarah Ahmed; Geidy E Serrano; Thomas G Beach; Matthew Perkins; Ann C Rice; Eliezer Masliah; Christopher M Morris; Lasse Pihlstrom; Alexander Pantelyat; Susan M Resnick; Mark R Cookson; Dena G Hernandez; Marilyn Albert; Ted M Dawson; Liana S Rosenthal; Henry Houlden; Olga Pletnikova; Juan Troncoso; Sonja W Scholz
Journal:  Neurobiol Dis       Date:  2019-02-21       Impact factor: 5.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.